Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Galectins: Multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment
María T. Elola, Fátima Ferragut, Santiago P. Méndez‐Huergo, et al.
Cellular Immunology (2018) Vol. 333, pp. 34-45
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
Stacy A. Malaker, Kayvon Pedram, Michael J. Ferracane, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 15, pp. 7278-7287
Open Access | Times Cited: 241
Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives
Laurenz Nagl, Lena Horvath, Andreas Pircher, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 146
The role of galectins in immunity and infection
Fu‐Tong Liu, Sean R. Stowell
Nature reviews. Immunology (2023) Vol. 23, Iss. 8, pp. 479-494
Open Access | Times Cited: 137
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V. Mariño, Alejandro J. Cagnoni, Diego O. Croci, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 295-316
Open Access | Times Cited: 137
An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma
Yifei Dai, Weijie Qiang, Kequan Lin, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 4, pp. 967-979
Open Access | Times Cited: 124
“Stuck on sugars – how carbohydrates regulate cell adhesion, recognition, and signaling”
Richard D. Cummings
Glycoconjugate Journal (2019) Vol. 36, Iss. 4, pp. 241-257
Open Access | Times Cited: 115
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
John L. Caniglia, Maheedhara R. Guda, Swapna Asuthkar, et al.
PeerJ (2020) Vol. 8, pp. e9392-e9392
Open Access | Times Cited: 84
Immunopathology of galectin-3: an increasingly promising target in COVID-19
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 70
Glycan Microarrays as Chemical Tools for Identifying Glycan Recognition by Immune Proteins
Chao Gao, Mohui Wei, Tanya R. McKitrick, et al.
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 67
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure
Andrea Portacci, Fabrizio Diaferia, Carla Santomasi, et al.
Respiratory Medicine (2021) Vol. 187, pp. 106556-106556
Open Access | Times Cited: 42
Immunopathology of galectin-3: an increasingly promising target in COVID-19
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 46
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growth
Fátima Ferragut, Alejandro J. Cagnoni, Lucas L. Colombo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1866, Iss. 8, pp. 1338-1352
Open Access | Times Cited: 43
Galectins in Endothelial Cell Biology and Angiogenesis: The Basics
Victor L. Thijssen
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1386-1386
Open Access | Times Cited: 31
Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression
Pablo Carabias, María V. Espelt, María L Bacigalupo, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
Daniela Adriana Oatis, Erika Simon-Repolski, Cornel Baltă, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8210-8210
Open Access | Times Cited: 22
Vascular galectins in tumor angiogenesis and cancer immunity
Victor L. Thijssen
Seminars in Immunopathology (2024) Vol. 46, Iss. 1-2
Open Access | Times Cited: 4
Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma
Angelica Pace, Fabio Scirocchi, Chiara Napoletano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6312-6312
Open Access | Times Cited: 16
Can Galectin-3 be a reliable predictive biomarker for post-COVID syndrome development?
Andrea Portacci, M Amendolara, Vitaliano Nicola Quaranta, et al.
Respiratory Medicine (2024) Vol. 226, pp. 107628-107628
Closed Access | Times Cited: 3
Full-length galectin-8 and separate carbohydrate recognition domains: the whole is greater than the sum of its parts?
Alejandro J. Cagnoni, María F. Troncoso, Gabriel A. Rabinovich, et al.
Biochemical Society Transactions (2020) Vol. 48, Iss. 3, pp. 1255-1268
Closed Access | Times Cited: 24
Methods of in vitro study of galectin-glycomaterial interaction
Viktoria Heine, Carina Dey, Pavla Bojarová, et al.
Biotechnology Advances (2022) Vol. 58, pp. 107928-107928
Closed Access | Times Cited: 14
Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb
Zohreh Varasteh, Francesco De Rose, Sarajo K. Mohanta, et al.
Theranostics (2020) Vol. 11, Iss. 4, pp. 1864-1876
Open Access | Times Cited: 23
Pre-B cell receptor acts as a selectivity switch for galectin-1 at the pre-B cell surface
Pauline Touarin, Bastien Serrano, Audrey Courbois, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114541-114541
Open Access | Times Cited: 2
Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
Guillermo A. Videla-Richardson, Olivia Morris-Hanon, Nicolás I. Torres, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 316-316
Open Access | Times Cited: 16
Expression Pattern and Immunoregulatory Roles of Galectin-1 and Galectin-3 in Atopic Dermatitis and Psoriasis
Mab P. Corrêa, Rebeca D. Correia-Silva, Gisela Rodrigues da Silva Sasso, et al.
Inflammation (2022) Vol. 45, Iss. 3, pp. 1133-1145
Closed Access | Times Cited: 11
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects
Javier Glez‐Vaz, Arantza Azpilikueta, María C. Ochoa, et al.
Science Advances (2023) Vol. 9, Iss. 33
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top